ascopubs.org

Landmark analysis of OS by response status in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post hoc analysis of the KEYNOTE-394 study.

This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text component.
ascopubs.org

Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of ...

Transition of molecular target agent therapy in advanced hepatocellular carcinoma: A multicenter, retrospective study. Results from the phase I dose-escalation study of the radiation enhancer NBTXR3 ...